MedPath

Folic Acid in Preventing Colorectal Polyps in Patients With Previous Colorectal Polyps

Not Applicable
Completed
Conditions
Adenoma of Large Intestine
Registration Number
NCT00512850
Lead Sponsor
Brigham and Women's Hospital
Brief Summary

RATIONALE: Chemoprevention is the use of certain substances to keep cancer from forming. The use of folic acid may prevent colorectal cancer.

PURPOSE: This randomized clinical trial is studying how well folic acid works compared with a placebo in preventing colorectal polyps in patients who have had previous colorectal polyps.

Detailed Description

OBJECTIVES:

Primary

* Determine if folic acid supplementation lowers the adenoma recurrence rate.

Secondary

* Determine the number of adenomas per patient and the size and histology of the adenoma.

* Assess the interaction between folic acid and alcohol, methionine, and aspirin intake.

* Assess the interaction between folic acid and pretrial and midtrial folate levels.

* Assess other complementary biomarkers such as DNA methylation and blood folate level as risk factors for polyp recurrence.

OUTLINE: Patients are randomized to 1 of 2 treatment arms.

* Arm I: Patients receive oral folic acid once daily.

* Arm II: Patients receive oral placebo once daily. At least 1 year after beginning treatment, patients are sent a blood collection kit in order to measure plasma vitamin B12 levels, to measure folate to assess compliance.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
672
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Recurrent colorectal adenomaMay 1996-March 2004
Secondary Outcome Measures
NameTimeMethod
recurrent adenoma by location, size, stage, number,May1996-March 2004

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.